At present, studies have attempted targeted intervention with STAT1 inhibitors and have shown positive tumor suppressor effects in a variety of solid tumors such as glioblastoma, squamous cell carcinoma, and colorectal cancer (72, 76, 77). This evidence concerns the gene STAT1 and glioblastoma.